share_log

Acer Therapeutics Q4 EPS $(0.54) Misses $(0.37) Estimate

Acer Therapeutics Q4 EPS $(0.54) Misses $(0.37) Estimate

宏碁治療第四季每股收益美元 (0.54) 未命中美元 (0.37) 估計
Benzinga ·  2023/03/27 16:03

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.37) by 45.95 percent. This is a 74.19 percent decrease over losses of $(0.31) per share from the same period last year.

宏碁治療公司(納斯達克:宏碁)公佈季度虧損為每股0.54美元,低於分析師一致預期的0.37美元,跌幅為45.95%。這比去年同期每股虧損0.31美元減少了74.19%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論